ECASX | RPMGX | ECASX / RPMGX | |
Total Expense Ratio | 1.87 | 0.75 | 249% |
Annual Report Gross Expense Ratio | 1.87 | 0.75 | 249% |
Fund Existence | 16 years | 33 years | - |
Gain YTD | -5.903 | 2.537 | -233% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 13.2B | 26.7B | 49% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | -12.41 | -5.53 | 224% |
Returns for 3 years | 3.78 | 19.23 | 20% |
Returns for 5 years | -8.77 | -4.29 | 204% |
Returns for 10 years | 11.75 | 28.82 | 41% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBP | 72.16 | 0.53 | +0.75% |
Virtus LifeSci Biotech Products ETF | |||
JCPB | 47.45 | 0.04 | +0.08% |
JPMorgan Core Plus Bond ETF | |||
KCE | 151.18 | 0.10 | +0.07% |
SPDR® S&P Capital Markets ETF | |||
IBDZ | 26.44 | -0.01 | -0.04% |
iShares iBonds Dec 2034 Term Corp ETF | |||
SCJ | 90.90 | -0.53 | -0.58% |
iShares MSCI Japan Small-Cap ETF |